Skip to content

Risk Factors and Immune Regulatory Mechanisms of COPD-Pulmonary Tuberculosis Comorbidity: A Cohort Study

Risk Factors and Immune Regulatory Mechanisms of COPD-Pulmonary Tuberculosis Comorbidity: A Cohort Study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600131255
Enrollment
Unknown
Registered
2026-08-31
Start date
2026-09-01
Completion date
Unknown
Last updated
2026-09-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic obstructive pulmonary disease and Tuberculosis

Interventions

Chronic obstructive pulmonary disease combined with tuberculosis comorbidity group:None

Sponsors

West China Hospital of Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1.Our respiratory and critical care medicine department and tuberculosis department ultimately diagnosed patients with chronic obstructive pulmonary disease, pulmonary tuberculosis, or comorbidities of both; 2.Complete clinical data; 3.The patient signs the informed consent form.

Exclusion criteria

Exclusion criteria: 1.Clinical data is incomplete; 2.Patients with other serious heart and lung diseases, malignant tumors, cranial lesions, and liver lesions; 3.The patient did not cooperate or the researcher deemed it unsuitable for inclusion;

Design outcomes

Primary

MeasureTime frame
gene expression differences;Diversity and specificity of T cell receptors;

Countries

China

Contacts

Public ContactShuang Zhao

West China Hospital of Sichuan University

zs_19881103@163.com+86 23 85422376

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Sep 19, 2026